Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage

JAMA Neurology

Volumn 74, Issue 2, 2017, Pages 173-180

  Renoux, Christel ^a,b   Vahey, Sarah ^a   Dell'Aniello, Sophie ^a   Boivin, Jean François ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE; AGED; ARTICLE; BINDING AFFINITY; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; GENERAL PRACTICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; UNITED KINGDOM; CHEMICALLY INDUCED; HEALTH CARE PLANNING; INTRACRANIAL HEMORRHAGES; MIDDLE AGED;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COHORT STUDIES; COMMUNITY HEALTH PLANNING; DEPRESSION; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; UNITED KINGDOM;

EID: 85014671872     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.4529     Document Type: Article

References (38)

1. Beck CA, Patten SB, Williams JV, et al. Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol. 2005;40(10):799-807.
2. Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom. 2008;77 (2):83-92.
3. Patten SB, Esposito E, Carter B. Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf. 2007;16(7):746-752.
4. Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study. Arch Intern Med. 2003;163(1):59-64.
5. de Abajo FJ, Rodríguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study. BMJ. 1999; 319(7217):1106-1109.
6. Bak S, Tsiropoulos I, Kjaersgaard JO, et al. Selective serotonin reuptake inhibitors and the risk of stroke: A population-based case-control study. Stroke. 2002;33(6):1465-1473.
7. Chen Y, Guo JJ, Li H, Wulsin L, Patel NC. Risk of cerebrovascular events associated with antidepressant use in patients with depression: A population-based, nested case-control study. Ann Pharmacother. 2008;42(2):177-184.
8. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol. 2000;50(1):43-47.
9. Douglas I, Smeeth L, Irvine D. The use of antidepressants and the risk of haemorrhagic stroke: A nested case control study. Br J Clin Pharmacol. 2011;71(1):116-120.
10. Kharofa J, Sekar P, Haverbusch M, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007;38(11):3049-3051.
11. Pan A, Okereke OI, Sun Q, et al. Depression and incident stroke in women. Stroke. 2011;42(10): 2770-2775.
12. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in theWomen's Health Initiative study. Arch Intern Med. 2009;169(22): 2128-2139.
13. Verdel BM, Souverein PC, Meenks SD, Heerdink ER, Leufkens HG, Egberts TC. Use of serotonergic drugs and the risk of bleeding. Clin Pharmacol Ther. 2011;89(1):89-96.
14. Wu CS, Wang SC, Cheng YC, Gau SS. Association of cerebrovascular events with antidepressant use: A case-crossover study. Am J Psychiatry. 2011;168 (5):511-521.
15. Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9(1):47-59.
16. Castro VM, Gallagher PJ, Clements CC, et al. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. BMJ Open. 2012;2(2):e000544.
17. Chen Y, Guo JJ, Patel NC. Hemorrhagic stroke associated with antidepressant use in patients with depression: Does degree of serotonin reuptake inhibition matter? Pharmacoepidemiol Drug Saf. 2009;18(3):196-202.
18. Meijer WE, Heerdink ER, NolenWA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med. 2004;164(21):2367-2370.
19. Movig KL, JanssenMW, deWaal Malefijt J, Kabel PJ, Leufkens HG, Egberts AC. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med. 2003;163(19):2354-2358.
20. vanWalraven C, Mamdani M.M, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study. BMJ. 2001;323(7314):655-658.
21. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827-836.
22. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350(9084):1097-1099.
23. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998; 45(5):419-425.
24. Chisholm J. The Read clinical classification. BMJ. 1990;300(6732):1092.
25. National Health Service. Dictionary of Medicines and Devices. http://www.nhsbsa.nhs.uk /PrescriptionServices/1121.aspx.
26. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991;302(6779):766-768.
27. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy. 2003;23(5):686-689.
28. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340(2-3):249-258.
29. Breslow NE, Day NE. Fitting models to continuous data. In: The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987:178-229. Statistical Methods in Cancer Research; vol 2.
30. Suissa S. Novel approaches to pharmacoepidemiology study design and statistical analysis. In: Strome BL, ed. Pharmacoepidemiology. 3rd ed. New York, NY: John Wiley & Sons Ltd; 2000: 785-805.
31. Essebag V, Platt RW, Abrahamowicz M, Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med ResMethodol. 2005;5(1):5.
32. Hackam DG, Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: Ameta-analysis. Neurology. 2012;79(18):1862-1865.
33. Daskalopoulou M, George J, Walters K, et al. Depression as a risk factor for the initial presentation of twelve cardiac, cerebrovascular, and peripheral arterial diseases: Data linkage study of 1.9 million women and men. PLoS One. 2016;11 (4):e0153838.
34. Li N, Wallén NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis. 1997;8(8):517-523.
35. Alvarez JC, Gluck N, Arnulf I, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine. Clin Pharmacol Ther. 1999;66(6):617-624.
36. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther. 2000;68(4):435-442.
37. Petersen EN, Bechgaard E, Sortwell RJ, Wetterberg L. Potent depletion of 5HT from monkey whole blood by a new 5HT uptake inhibitor, paroxetine (FG 7051). Eur J Pharmacol. 1978;52(1):115-119.
38. Schalekamp T, Klungel OH, Souverein PC, de Boer A. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med. 2008;168(2):180-185.